These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8100402)

  • 41. Treatment outcome of schizophrenia co-morbid with obsessive-compulsive disorder.
    Sayeed Khan MN; Arshad N; Ullah N
    J Coll Physicians Surg Pak; 2004 Apr; 14(4):234-6. PubMed ID: 15228829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
    Zink M; Englisch S; Knopf U; Kuwilsky A; Dressing H
    Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353
    [No Abstract]   [Full Text] [Related]  

  • 43. Fluoxetine treatment of obsessive-compulsive disorder: an open clinical trial.
    Liebowitz MR; Hollander E; Schneier F; Campeas R; Hatterer J; Papp L; Fairbanks J; Sandberg D; Davies S; Stein M
    J Clin Psychopharmacol; 1989 Dec; 9(6):423-7. PubMed ID: 2687337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A case of fluoxetine-responsive psychogenic polydipsia: a variant of obsessive-compulsive disorder?
    Deas-Nesmith D; Brewerton TD
    J Nerv Ment Dis; 1992 May; 180(5):338-9. PubMed ID: 1583478
    [No Abstract]   [Full Text] [Related]  

  • 45. Successful treatment of tuberous sclerosis with psychosis and obsessive-compulsive disorder: A case report.
    Rao SA; Rao MG; Rao NP; Varambally S; Gangadhar BN
    Psychiatry Clin Neurosci; 2015 Aug; 69(8):504-5. PubMed ID: 25907259
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of clinical characteristics, co-morbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder.
    Poyurovsky M; Faragian S; Shabeta A; Kosov A
    Psychiatry Res; 2008 May; 159(1-2):133-9. PubMed ID: 18406469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reply to Dr Mahendran. We have not found reported cases of [obsessive-compulsive] OC arising from de novo with olanzapine treatment.
    Safranko I
    Aust N Z J Psychiatry; 2003 Feb; 37(1):112. PubMed ID: 12534671
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
    Simeon JG; Thatte S; Wiggins D
    Psychopharmacol Bull; 1990; 26(3):285-90. PubMed ID: 2274627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder.
    Fontaine R; Chouinard G
    J Clin Psychopharmacol; 1986 Apr; 6(2):98-101. PubMed ID: 3517083
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder.
    Grady TA; Pigott TA; L'Heureux F; Hill JL; Bernstein SE; Murphy DL
    Am J Psychiatry; 1993 May; 150(5):819-21. PubMed ID: 8480832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Obsessive compulsive disorder, depression, and fluoxetine.
    Hollander E; Mullen L; DeCaria CM; Skodol A; Schneier FR; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treating depression in schizophrenia.
    Lund BC; Perry PJ; Miller DD
    Am J Psychiatry; 2001 Sep; 158(9):1528-9. PubMed ID: 11532750
    [No Abstract]   [Full Text] [Related]  

  • 53. Cyproheptadine in treatment-resistant chronic schizophrenics with prior negative response to fluoxetine.
    Bacher NM; Sanzone MM; Kaup B
    J Clin Psychopharmacol; 1994 Dec; 14(6):424-5. PubMed ID: 7884024
    [No Abstract]   [Full Text] [Related]  

  • 54. Trazodone-fluoxetine combination for treatment of obsessive-compulsive disorder.
    Swerdlow NR; Andia AM
    Am J Psychiatry; 1989 Dec; 146(12):1637. PubMed ID: 2589561
    [No Abstract]   [Full Text] [Related]  

  • 55. Managing psychotic symptoms when the diagnosis is unclear.
    Ninan PT; Shelton S
    Hosp Community Psychiatry; 1993 Feb; 44(2):107-8. PubMed ID: 8432491
    [No Abstract]   [Full Text] [Related]  

  • 56. Obsessive-compulsive disorder, fluoxetine, and buspirone.
    Sternlicht HC
    Am J Psychiatry; 1993 Mar; 150(3):526. PubMed ID: 8434680
    [No Abstract]   [Full Text] [Related]  

  • 57. Development of obsessive-compulsive symptoms during clozapine treatment.
    Patel B; Tandon R
    Am J Psychiatry; 1993 May; 150(5):836. PubMed ID: 8480835
    [No Abstract]   [Full Text] [Related]  

  • 58. Mutism as a component of obsessive-compulsive symptoms in patients with schizophrenia: A report of two cases.
    Vani P; Nadella RK; Viswanath B; Jain S
    Asian J Psychiatr; 2020 Dec; 54():102337. PubMed ID: 32795956
    [No Abstract]   [Full Text] [Related]  

  • 59. Buspirone and fluoxetine in the treatment of OCD.
    Judd F; Ellen S; Norman T
    Aust N Z J Psychiatry; 1992 Dec; 26(4):684-6. PubMed ID: 1476539
    [No Abstract]   [Full Text] [Related]  

  • 60. Obsessive compulsive symptoms (OCS) in patients with schizophrenia are rare.
    Mavrogiorgou P; Dünnweber M; Juckel G
    Schizophr Res; 2016 Jul; 174(1-3):197-199. PubMed ID: 27086169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.